Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Diabetes Research, enter your email address in the box below.

Journal of Diabetes Research
Volume 2017 (2017), Article ID 6915310, 9 pages
https://doi.org/10.1155/2017/6915310
Research Article

Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension

Ulla Kampmann,1 Ole N. Mathiassen,2 Kent L. Christensen,2 Niels H. Buus,3 Mette Bjerre,4 Henrik Vase,2 Niels Møller,1,4 Anne Kaltoft,2 and Per L. Poulsen1

1Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark
2Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark
3Department of Nephrology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark
4Medical Research Laboratory, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark

Correspondence should be addressed to Ulla Kampmann; kd.purtspo@allu

Received 28 March 2017; Revised 9 July 2017; Accepted 25 July 2017; Published 7 September 2017

Academic Editor: Joseph F. Ndisang

Copyright © 2017 Ulla Kampmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ferrannini and W. Cushman, “Diabetes and hypertension: the bad companions,” Lancet, vol. 380, pp. 601–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Schlaich, D. Hering, P. Sobotka et al., “Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension,” Frontiers in Physiology, vol. 3, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. V. S. Ram and A. S. Kumar, “Renal denervation therapy for resistant hypertension: a clinical update,” Journal of Human Hypertension, vol. 12, pp. 699–704, 2014. View at Google Scholar
  4. Simplicity HTN-2 Investigators, “Renal sympathetic denervation in patients with treatment-resistant hypertension (the simplicity HTN-2 trial): a randomised controlled trial,” Lancet, vol. 376, pp. 1903–1909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Bhatt, D. E. Kandzari, W. W. O'Neill et al., “A controlled trial of renal denervation for resistant hypertension,” The New England Journal of Medicine, vol. 370, pp. 1393–1401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Desch, T. Okon, D. Heinemann et al., “Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension,” Hypertension, vol. 65, pp. 1202–1208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Harrison, “The immune system in hypertension,” Transactions of the American Clinical and Climatological Association, vol. 125, pp. 130–138, 2014. View at Google Scholar
  8. S. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. O. N. Mathiassen, H. Vase, J. N. Bech et al., “Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial,” Journal of Hypertension, vol. 34, pp. 1639–1647, 2016. View at Google Scholar
  10. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, pp. 214–223, 1979. View at Google Scholar
  11. U. Kampmann, P. Hoeyem, A. Mengel et al., “Insulin dose-response studies in severely insulin-resistant type 2 diabetes—evidence for effectiveness of very high insulin doses,” Diabetes, Obesity & Metabolism, vol. 13, pp. 511–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Hother-Nielsen and H. Beck-Nielsen, “On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion,” Diabetologia, vol. 33, pp. 603–610, 1990. View at Google Scholar
  13. R. Steele, “Influences of glucose loading and of injected insulin on hepatic glucose output,” Annals of the New York Academy of Sciences, vol. 82, pp. 420–430, 1959. View at Google Scholar
  14. R. C. Debodo, R. Steele, N. Altszuler, A. Dunn, and J. S. Bishop, “On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose,” Recent Progress in Hormone Research, vol. 19, pp. 445–488, 1963. View at Google Scholar
  15. J. Radziuk, K. H. Norwich, and M. Vranic, “Experimental validation of measurements of glucose turnover in nonsteady state,” The American Journal of Physiology, vol. 234, pp. 84–93, 1978. View at Google Scholar
  16. E. Ferrannini, “The theoretical bases of indirect calorimetry: a review,” Metabolism, vol. 37, pp. 287–301, 1988. View at Google Scholar
  17. N. Moller, P. C. Butler, M. A. Antsiferov, and K. G. Alberti, “Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man,” Diabetologia, vol. 32, pp. 105–110, 1989. View at Google Scholar
  18. J. Frystyk, L. Tarnow, T. K. Hansen, H. H. Parving, and A. Flyvbjerg, “Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications,” Diabetologia, vol. 48, pp. 1911–1918, 2005. View at Google Scholar
  19. H. Orskov, H. G. Thomsen, and H. Yde, “Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone,” Nature, vol. 219, pp. 193–195, 1968. View at Google Scholar
  20. J. Frystyk, B. Dinesen, and H. Orskov, “Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II,” Growth Regulation, vol. 5, pp. 169–176, 1995. View at Google Scholar
  21. A. K. Miroslawka, P. F. Gjessing, M. D. Solbu, O. M. Fuskevåg, T. G. Jenssen, and T. K. Steigen, “Renal denervation for resistant hypertension fails to improve insulin resistance as assessed by hyperinsulinemic euglycemic step clamp,” Diabetes, vol. 65, pp. 2164–2168, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Iyer, R. N. Bergman, J. E. Korman et al., “Renal denervation reverses hepatic insulin resistance induced by high-fat diet,” Diabetes, vol. 65, pp. 3453–3463, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Chen, R. Chen, H. Wang, and F. Liang, “Mechanisms linking inflammation to insulin resistance,” International Journal of Endocrinology, vol. 2015, Article ID 508409, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Schlaich, N. Straznicky, M. Grima et al., “Renal denervation: a potential new treatment modality for polycystic ovary syndrome?” Journal of Hypertension, vol. 29, pp. 991–996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Mahfoud, M. Schlaich, I. Kindermann et al., “Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study,” Circulation, vol. 123, pp. 1940–1946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. W. L. Verloop, W. Spiering, E. E. Vink et al., “Denervation of the renal arteries in metabolic syndrome: the DREAMS-study,” Hypertension, vol. 65, pp. 751–757, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Wassertheil-Smoller, G. Anderson, B. M. Psaty et al., “Hypertension and its treatment in postmenopausal women baseline data from the women’s health initiative,” Hypertension, vol. 36, pp. 780–789, 2000. View at Google Scholar